Adult Immunization

 
2025-2026 Flu Season: Reduced Vaccine Match May Lead to Increased Transmission and Severity, Experts Warn
November 24, 2025

The H3N2 subclade K is dominating early flu season gobally; despite vaccine mismatch, vaccination remains the primary defense against severe illness and hospitalization.

CDC Updates Website Page to Implicate Vaccines in Autism
November 21, 2025

The CDC website now claims "studies supporting a link [between vaccines and autism] have been ignored by health authorities."

Quadrivalent modRNA Influenza Vaccine Shows Superior Efficacy to Licensed Inactivated Vaccine in Phase 3 Trial
November 20, 2025

Results showed that Pfizer’s mRNA vaccine cut influenza-like illness by 34.5% compared with a standard influenza vaccine.

Weekly Dose Podcast: New Insights on Colonoscopy Adherence, rt-CGM in GDM, Semaglutide Effects, Parent Vaccine Views, and MI Causes
November 13, 2025

Topics include rideshare support for colonoscopy, rt-CGM benefits in GDM, semaglutide and food noise, vaccine views, and MI etiology.

Kelly Moore, MD, MPH, is Concerned About COVID-19 Vaccination Equity in Post-Universal Coverage America
October 02, 2025

Moore describes the ACIP's shared decision making approach to COVID-19 vaccination as a "passive recommendation" that will surely exclude at-risk US populations.

The End of Universal COVID-19 Vaccine Coverage Doesn't Mean the End of Payer Coverage, At Least Not for 2026: A Conversation with Kelly Moore, MD, MPH
September 30, 2025

Public health expert Kelly Moore, MD, MPH, president and CEO of immunize.org, says the news is good for now, but the uninsured could be at future risk.

New Local, Regional Vaccine Recommendations Reflect Low Confidence in ACIP, HHS: Kelly Moore, MD, MPH
September 29, 2025

Public health officials across states and regions are "thinking on their feet" about how best to protect public health given the upheavel in federal vaccine policy, Moore said.

RSV Vaccines Found Safe and Effective Across High-Risk Groups in Cochrane Review
September 29, 2025

Vaccines for respiratory syncytial virus were found both safe and effective across 100,000 participants and, critically, for older adults and infants.

Adult Immunization in the US: Status, Gaps, and Forward Strategy
September 26, 2025

Adult vaccine-preventable diseases cost $26.5B annually in the US. See key gaps, barriers, and strategies primary care physicians can use to boost immunization.

High-Dose Flu Vaccine Cuts Myocarditis, Pericarditis Risk in Older Adults: Daily Dose
September 25, 2025

Your daily dose of the clinical news you may have missed.